Introduction
cardiac injury, COVID-19 syndrome, cardiac abnormalities, myocardial inflammation
CORONAVIRUS, MYOCARDIAL INFLAMMATION, SEVERE ACUTE RESPIRATORY SYNDROME
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in more than 541 million infected cases, as of June 2022. Even though most infected patients recover, around 10–30% remain with persistent symptoms that can significantly affect their quality of lifeThe long-term impact of COVID-19 associated cardiac injury has recently been revealed. A radiological study of 100 discharged COVID-19 patients found cardiac abnormalities and myocardial inflammation in 78% and 60% of participants, respectively, which were not associated with the initial COVID-19 severityCurrently, treatment options for post-COVID-19 condition include targeted anti-inflammatory molecules and specific diets. However, none have been determined effectiveIn recent years, evidence has accumulated about hyperbaric oxygen therapy’s (HBOT) efficacyThe aim of the current study was to evaluate the effects of HBOT on cardiac function in patients suffering from the post COVID-19 syndrome in a randomized, sham-control, double-blind clinical trial.